Across multiple experimental settings that involve the upregulation and downregulation of JTB in MCF7 BC cells [12,13,14,15,16,17], a consistent pattern of biological disruption was observed, indicating JTB’s pivotal role in modulating key tumorigenic processes (Figure 4). The gene discussed is JTB; the disease is breast cancer.